MCK
vs
S&P 500
Over the past 12 months, MCK has underperformed S&P 500, delivering a return of 21% compared to the S&P 500's 24% growth.
Stocks Performance
MCK vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
IT |
Amplifon SpA
MIL:AMP
|
||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
Performance Gap
MCK vs S&P 500
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
IT |
Amplifon SpA
MIL:AMP
|
||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
Performance By Year
MCK vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
Cencora Inc
NYSE:COR
|
||
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
US |
Cardinal Health Inc
NYSE:CAH
|
||
US |
Henry Schein Inc
NASDAQ:HSIC
|
||
KR |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
||
IT |
Amplifon SpA
MIL:AMP
|
||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
Competitors Performance
Mckesson Corp vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
LU |
Tenaris SA
MIL:TEN
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Mckesson Corp
Glance View
McKesson Corporation, with its roots tracing back to 1833, stands as a healthcare titan in the pharmaceutical industry. Founded by John McKesson and Charles Olcott in New York City, the company began its journey as an importer and wholesaler of botanical drugs. McKesson has since evolved into one of the largest healthcare companies in the world, delivering critical logistics and distribution services that underpin the healthcare sector. The company's primary role is that of an intermediary, ensuring that pharmaceutical products and medical supplies make their way efficiently from manufacturers to pharmacies, hospitals, and clinics. This pivotal position places McKesson at the heart of the supply chain, making health products more accessible and affordable across North America and beyond. The operational mechanics of McKesson are a complex yet seamless orchestration of advanced logistics, technology, and customer service. By maintaining a vast network of distribution centers, the corporation processes and ships millions of pharmaceutical products daily, ensuring they are delivered within stringent timeframes. Through its well-oiled logistics system, McKesson earns its revenue mainly from the margins on product sales and the fees it charges for its distribution services. Furthermore, the company has diversified into additional areas like healthcare technology solutions, offering software and automation systems that aid healthcare providers in managing their operations more effectively. In summary, McKesson remains an indispensable player in healthcare, translating logistical prowess into a streamlined flow of pharmaceuticals from production to patient care.